semaglutide injection fda approval Ozempic is first GLP-1 drug FDA-approved for kidney disease US FDA approves weight loss

Starting tirzepatide at 2.5 mg allows receptors to re-sensitize before escalating, which improves long-term response

Potential Mechanisms Behind GLP-1 Effects on Addictive Behaviours Understanding the biological mechanisms through which GLP-1 receptor agonists might influence addictive behaviours requires examining the neuroanatomy of reward processing and how these medications interact with relevant brain circuits

Although its only approved as a diabetes medication, getting Ozempic specifically for weight loss is possible

This leads to reduced appetite and earlier satiety, further promoting caloric reduction leading to weight loss

But you may need more water if youre highly active